A Texas Tech professor's nine-year effort research effort to develop an anthelmintic drug for parasite control in wild quail populations has gotten the final nod of approval from the FDA.

Triclabendazole is an anthelmintic and the drug of choice recommended by the World Health Organization for the treatment of fascioliasis (a parasitic worm infection caused by the common liver fluk ...